INS and type 2 diabetes mellitus: The strength of this study was that it was a multicenter study, and only required type 2 diabetes with insulin-treated and non-insulin-treated to have at least three FCG and three PCG measurements, indicating that this study had good extrapolation in type 2 diabetes.